Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flumatinib with Chemotherapy in Ph+ ALL
NCT04375683Phase 3Unknown
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Mar 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Flumatinib in acute lymphoblastic leukemia (ALL), sponsored by Zhongda Hospital, Southeast University. Status: unknown.
02
Drugs
Flumatinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT04375683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04375683.